Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.

Pochopien, Michal; Cherney, David Z I; Drzewiecka, Aleksandra; Folkerts, Kerstin; Levy, Pierre; Millier, Aurélie; Morris, Stephen; Palarczyk, Monika; Roy-Chaudhury, Prabir; Sullivan, Sean D; Mernagh, Paul

Pochopien, Michal; Cherney, David Z I; Drzewiecka, Aleksandra; Folkerts, Kerstin; Levy, Pierre; Millier, Aurélie; Morris, Stephen; Palarczyk, Monika; Roy-Chaudhury, Prabir; Sullivan, Sean D; Mernagh, Paul.

Affiliation

Pochopien M; Przemyslowa 12, 30-701 Kraków, Poland. E-mail: michal.pochopien@creativ-ceutical.com.

Am J Manag Care ; 28(6 Suppl): S104-S111, 2022 08.

Article in En | MEDLINE | ID: mdl-35997774

Subject(s)

Cardiovascular Diseases; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Disease Progression; Humans; Renal Insufficiency, Chronic/complications; Renal Insufficiency, Chronic/drug therapy; Renal Insufficiency, Chronic/epidemiology; Technology Assessment, Biomedical

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Etiology_studies / Health_technology_assessment / Prognostic_studies Limits: Humans Language: En Journal: Am J Manag Care Journal subject: SERVICOS DE SAUDE Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google